Tevogen Bio Holdings Inc (TVGN) Stock Price, Quote & News

Company Profile

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 pat...

Industry: Biotechnology

Sector: Healthcare

Phone: 877 838 6434

Website: tevogen.com

Address:

15 Independence Boulevard, Suite #210, Warren, United States

bangbanga Jul. 16 at 2:09 AM

$TVGN They quietly increased the share count by 50% — from 4 million shares to 6 million. Typical behavior of a scam stock. Stay away from this stock. Do not invest. It's a scam.

0 · Reply

LuigiV_ Jul. 14 at 7:36 PM

$SILO $ADVB $UPLD $TVGN wod

0 · Reply

NGCS Jul. 14 at 1:17 PM

$TVGN IMO Big corporate update: $TVGN just announced the 2026 Annual Meeting of Stockholders for Aug 24th, with the Record Date set for July 23rd. 🗓️ This is a massive tell. Management is setting a strict timeline. They have exactly until July 23rd to lock down voting rights and clean up the shareholder registry. Expect the definitive MSO/CRO binding agreements to drop before then so they can present a $100M+ commercial powerhouse to shareholders. Tick-tock. NFA.

0 · Reply

LuigiV_ Jul. 13 at 7:01 PM

$PRHI $SLMT $TVGN $TLIH idea

0 · Reply

NGCS Jul. 10 at 10:06 PM

$TVGN This is how you know the MSO deal is progressing exactly as planned. The board just approved a share package for the CEO tied strictly to hitting $100 MILLION in revenue. Not time-based, but PERFORMANCE-based. The exact number from the MSO LOI. They aren't guessing; they are preparing the execution. Buying at these manipulated sub-$6 levels is an absolute gift while the market remains blind to the SEC filings. Bullish. 🚀🔥

0 · Reply

NGCS Jul. 10 at 10:04 PM

$TVGN Insiders aren't betting on stock price pumps; they are betting on REAL REVENUE. New SEC forms show the CEO's new shares vest ONLY when $TVGN achieves $100M & $150M in revenue milestones. The infrastructure for the MSO agreement is being locked into place. While retail panics over low-volume algo manipulation, management is setting up the runway for massive fundamental growth. IMO Load up and hold. 🧘‍♂️🛡️NFA Best regards!

1 · Reply

bangbanga Jul. 10 at 9:07 PM

$TVGN TVGN, the famous scam company, will eventually get delisted for falling short of the market cap requirement. Mark my words

0 · Reply

MrAlientrader Jul. 10 at 4:03 PM

$TVGN the whole retreat had very small volume. Likely manipulated down not real sell. I am buying back my shares now, 40% cheaper than institutes bought recently

0 · Reply

stinstewart Jul. 1 at 6:49 PM

$TVGN https://www.globenewswire.com/news-release/2026/03/13/3255767/0/en/Tevogen-Reaffirms-Capital-Discipline-as-Lead-Investor-Maintains-Holdings-and-Company-Limits-Share-Utilization.html

1 · Reply

stinstewart Jul. 1 at 6:47 PM

$TVGN https://x.com/i/status/2072381998430122125

0 · Reply

Tevogen Bio Announces 2026 Annual Meeting of Stockholders

2026-06-12T21:05:21.000Z - 4 weeks ago

Tevogen files to sell 375,000 shares of common stock for holders

Jun 9, 2026, 3:30 PM EDT - 5 weeks ago

Tevogen Announces Formation of a Healthcare Services Initiative

2026-05-28T17:30:06.000Z - 6 weeks ago

Tevogen advances strategic acquisition initiatives

May 28, 2026, 12:30 PM EDT - 6 weeks ago

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

May 21, 2026, 12:15 PM EDT - 7 weeks ago

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

May 18, 2026, 12:15 PM EDT - 2 months ago

Letter to Shareholders from CEO Dr. Ryan Saadi

2026-05-12T18:10:14.000Z - 2 months ago

Tevogen Bio Holdings Inc trading halted, volatility trading pause

2026-05-12T18:07:55.000Z - 2 months ago

Tevogen Bio Holdings Inc trading resumes

May 12, 2026, 11:45 AM EDT - 2 months ago

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close

Apr 27, 2026, 11:50 AM EDT - 2 months ago

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal

Mar 26, 2026, 12:45 PM EDT - 3 months ago

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth

2026-03-25T18:25:30.000Z - 4 months ago

Tevogen regains compliance with Nasdaq minimum bid price requirement

Mar 25, 2026, 2:20 PM EDT - 4 months ago

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

Mar 18, 2026, 12:22 PM EDT - 4 months ago

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)

Mar 13, 2026, 2:45 PM EDT - 4 months ago

Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization

2026-03-13T16:40:31.000Z - 4 months ago

Tevogen reports performance advancements for Tevogen.AI platform

Mar 13, 2026, 12:30 PM EDT - 4 months ago

Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure

Mar 11, 2026, 3:15 PM EDT - 4 months ago

Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform

2026-03-09T11:51:22.000Z - 4 months ago

Tevogen appoints interim leaders across core business verticals

Mar 9, 2026, 7:45 AM EDT - 4 months ago

Tevogen Names Leadership Team to Execute Diversified Growth Strategy

2026-03-06T20:45:38.000Z - 4 months ago

Tevogen CEO says ‘actively evaluating potential acquisitions’

2026-03-06T15:20:39.000Z - 4 months ago

Tevogen Bio Holdings Inc trading resumes

2026-03-06T15:15:32.000Z - 4 months ago

Tevogen Bio Holdings Inc trading halted, volatility trading pause

2026-03-06T00:51:12.000Z - 4 months ago

Tevogen Bio Holdings Inc trading halted, news pending

2026-03-05T20:00:17.000Z - 4 months ago

Tevogen signs LOI to evaluate potential acquisition of Apozeal Pharmaceutical

Mar 5, 2026, 2:50 PM EST - 4 months ago

Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical

2026-03-04T14:23:36.000Z - 4 months ago

Tevogen downgraded to Hold from Buy at D. Boral Capital

2026-03-04T13:13:07.000Z - 4 months ago

Tevogen announces 50-for-1 reverse stock split

Mar 4, 2026, 8:00 AM EST - 4 months ago

Tevogen Announces Reverse Stock Split

2026-02-27T19:25:58.000Z - 4 months ago

Tevogen signs LoI to evaluate acquisition of contract research organization

Feb 27, 2026, 2:20 PM EST - 4 months ago

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

Feb 26, 2026, 4:22 PM EST - 4 months ago

UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus

2026-02-26T14:39:08.000Z - 4 months ago

Tevogen signs non-binding LOI to evaluate acquisition of Sciometrix

Feb 26, 2026, 9:20 AM EST - 4 months ago

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus

2026-01-30T20:05:31.000Z - 5 months ago

Tevogen to evaluate potential one-time special cash dividend

Jan 30, 2026, 3:00 PM EST - 5 months ago

Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders

Jan 29, 2026, 2:45 PM EST - 5 months ago

Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue

2026-01-12T14:11:33.000Z - 6 months ago

Tevogen reports scientific, operational milestones achieved in 2025

Jan 12, 2026, 9:00 AM EST - 6 months ago

Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025

Dec 22, 2025, 12:40 PM EST - 7 months ago

Tevogen CEO Donates Shares to Support Education for Underprivileged Children

Dec 19, 2025, 11:10 AM EST - 7 months ago

Tevogen CEO Donates Personal Shares to Support Local Fire Department

Dec 11, 2025, 3:15 PM EST - 7 months ago

Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company's Shares of Common Stock

Dec 9, 2025, 2:20 PM EST - 7 months ago

Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine

Dec 8, 2025, 2:50 PM EST - 7 months ago

Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook

Nov 14, 2025, 2:32 PM EST - 8 months ago

Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q

2025-11-05T20:25:58.000Z - 9 months ago

Tevogen announces clinical milestone in evolution of ExacTcell platform

Nov 5, 2025, 3:20 PM EST - 9 months ago

Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID

Nov 3, 2025, 2:45 PM EST - 9 months ago

Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn

Oct 29, 2025, 12:35 PM EDT - 9 months ago

Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress

Oct 15, 2025, 3:50 PM EDT - 9 months ago

Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest

Sep 25, 2025, 8:30 AM EDT - 10 months ago

Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion

Sep 23, 2025, 8:30 AM EDT - 10 months ago

Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID

Sep 19, 2025, 3:40 PM EDT - 10 months ago

Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489's Potential Impact for 20 Million Americans

Sep 10, 2025, 11:59 AM EDT - 11 months ago

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston

Sep 9, 2025, 3:15 PM EDT - 11 months ago

Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection

Sep 8, 2025, 9:27 AM EDT - 11 months ago

Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform

Sep 4, 2025, 3:48 PM EDT - 11 months ago

Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas

Sep 3, 2025, 4:15 PM EDT - 11 months ago

Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2

Aug 27, 2025, 3:20 PM EDT - 11 months ago

Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation Disclosure

Aug 26, 2025, 2:50 PM EDT - 11 months ago

Tevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company's Mission of Health Equity

Aug 25, 2025, 3:10 PM EDT - 11 months ago

Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions

Aug 22, 2025, 3:25 PM EDT - 11 months ago

Tevogen Recognized in BINJE's BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma

Aug 19, 2025, 3:40 PM EDT - 11 months ago

REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts

Aug 19, 2025, 12:10 PM EDT - 11 months ago

Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum

Aug 18, 2025, 5:50 PM EDT - 11 months ago

Tevogen CEO Donates Personal Shares to Support Local Law Enforcement

Aug 18, 2025, 5:15 PM EDT - 11 months ago

Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery

Aug 14, 2025, 3:55 PM EDT - 11 months ago

Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected

Aug 13, 2025, 3:53 PM EDT - 1 year ago

Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

bangbanga Jul. 16 at 2:09 AM

$TVGN They quietly increased the share count by 50% — from 4 million shares to 6 million. Typical behavior of a scam stock. Stay away from this stock. Do not invest. It's a scam.

0 · Reply

LuigiV_ Jul. 14 at 7:36 PM

$SILO $ADVB $UPLD $TVGN wod

0 · Reply

NGCS Jul. 14 at 1:17 PM

0 · Reply

LuigiV_ Jul. 13 at 7:01 PM

$PRHI $SLMT $TVGN $TLIH idea

0 · Reply

NGCS Jul. 10 at 10:06 PM

0 · Reply

NGCS Jul. 10 at 10:04 PM

1 · Reply

bangbanga Jul. 10 at 9:07 PM

$TVGN TVGN, the famous scam company, will eventually get delisted for falling short of the market cap requirement. Mark my words

0 · Reply

MrAlientrader Jul. 10 at 4:03 PM

$TVGN the whole retreat had very small volume. Likely manipulated down not real sell. I am buying back my shares now, 40% cheaper than institutes bought recently

0 · Reply

stinstewart Jul. 1 at 6:49 PM

$TVGN https://www.globenewswire.com/news-release/2026/03/13/3255767/0/en/Tevogen-Reaffirms-Capital-Discipline-as-Lead-Investor-Maintains-Holdings-and-Company-Limits-Share-Utilization.html

1 · Reply

stinstewart Jul. 1 at 6:47 PM

$TVGN https://x.com/i/status/2072381998430122125

0 · Reply

Market_Paradise Jul. 1 at 5:43 PM

Small caps heating up, We are seeing some big runners lately. Take a look at ticker DRCT 💎 I believe this is the next monster runner waiting to be found: DRCT 💎 • 600K share float! • AI-powered digital advertising & marketing drive. • Extremely thin chart. • Any sustained buying pressure we look for the 5$+. $CDT $RNAZ $SSP $TVGN .12

0 · Reply

NGCS Jul. 1 at 2:46 PM

$PGY In 2 months it became true, so now it is time for $TVGN (IMO will become 12 usd in few days... exactly from $6 to 11,95$ again, getting a x2 --- 200%) NFA. Best regards!

0 · Reply

NGCS Jul. 1 at 9:21 AM

$TVGN Let’s look at the facts instead of the panic: $TVGN recently closed a private investment at $8.00/share. Today's drop under $6 on less than 5k volume is a classic liquidity trap, not a reflection of the company's real value. The quiet period is legally mandatory while the final MSO/CRO contracts are being drafted. If you liked the story at $8, this is just a technical gift created by short-term algorithm manipulation. Stay calm.

1 · Reply

NGCS Jul. 1 at 9:15 AM

$TVGN A falling stock price on microscopic volume doesn't mean a failing business. The $TVGN chart is bleeding purely due to a dry order book and algos walking the price down with a handful of shares. No new filings, no bankruptcy, no fundamental changes. Smart money knows the approved S-3 shelf is the runway for the $100M MSO deal. Ignore the daily noise, the structural thesis is intact. 🧘‍♂️💎 NFA

0 · Reply

bangbanga Jul. 1 at 5:16 AM

$TVGN This is a notorious scam company. They use shareholders as an endless ATM, keep diluting the stock without end, and continue scamming investors while draining every last dollar from them.

0 · Reply

NGCS Jun. 30 at 9:00 AM

$TVGN IMO friday and momday, Algos and shorts paper-handing over a standard S-3 shelf registration (thursday) tells you everything you need to know about market literacy. $TVGN didn’t dump on fundamentals; it got stop-loss hunted on microscopic volume. A shelf registration is a pre-approved toolkit for future MSO execution, not an immediate cash dump. The spring is coiled tight. Weak hands got shook, smart money averages down. 📉❌🚀 NFA

1 · Reply